Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724399 | SCV000232422 | uncertain significance | not provided | 2014-12-18 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000180061 | SCV000711058 | uncertain significance | not specified | 2016-06-20 | criteria provided, single submitter | clinical testing | The p.Ala5049Thr variant in GPR98 has not been previously reported in individual s with hearing loss. This variant has been identified in 6/115918 of the total c hromosomes in the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute .org; dbSNP rs376376418). Although this variant has been seen in the general pop ulation, its frequency is not high enough to rule out a pathogenic role. Computa tional prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. In summary, the clinical significance o f the p.Ala5049Thr variant is uncertain. |
Fulgent Genetics, |
RCV002478599 | SCV002780341 | uncertain significance | Usher syndrome type 2C; Febrile seizures, familial, 4 | 2021-11-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000724399 | SCV002936551 | likely benign | not provided | 2025-01-13 | criteria provided, single submitter | clinical testing |